BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/15/2016 10:30:00 AM | Browse: 1536 | Download: 2158
Publication Name World Journal of Gastroenterology
Manuscript ID 26218
Country United States
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma
Manuscript Source Invited Manuscript
All Author List Chung-Tzu Hsueh, Julie H Selim, James Y Tsai and Chung-Tsen Hsueh
Funding Agency and Grant Number
Corresponding Author Chung-Tsen Hsueh, MD, PhD, Division of Medical Oncology and Hematology, Department of Internal Medicine, Loma Linda University, 11175 Campus Street, CSP 11015, Loma Linda, CA 92354, United States. chsueh@llu.edu
Key Words Pancreatic adenocarcinoma; Nanovector; Nanoparticle albumin-bound paclitaxel; Nanoliposomal irinotecan; Biomarker
Core Tip The nanovector-based anti-cancer therapeu-tics play important role in the treatment of advanced pancreatic adenocarcinoma. Data from completed clinical trials are reviewed, and important ongoing studies are presented. Biomarkers for patient selection and personalized medicine are discussed.
Publish Date 2016-08-15 10:30
Citation Hsueh CT, Selim JH, Tsai JY, Hsueh CT. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World J Gastroenterol 2016; 22(31): 7080-7090
URL http://www.wjgnet.com/1007-9327/full/v22/i31/7080.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i31.7080
Full Article (PDF) WJG-22-7080.pdf
Full Article (Word) WJG-22-7080.doc